We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
The classification of mature neoplasms has evolved over the years, with the current WHO classification based largely on the genetics and cellular origin of lymphoid neoplasms [1]. Clinical behaviour of lymphoid neoplasms, however, continues to play an important role in defining disease entities. Mature lymphoid neoplasms in the case of leukaemias primarily involve blood and bone marrow (BM), while in lymphomas, most entities, with an occasional exception (e.g. Waldenström macroglobulinaemia/lymphoplasmacytic lymphoma) show predominant involvement of extramedullary sites/site with secondary involvement of the bone marrow (BM). In patients with lymphomas, the BM may be biopsied as part of staging (e.g. follicular lymphoma) or when the primary site of involvement is not amenable to biopsy (e.g. primary splenic lymphomas such as splenic marginal zone lymphoma or hepatosplenic T-cell lymphoma). Less commonly, a mature lymphoid neoplasm may be an unexpected or suspected diagnosis initially made on BM biopsy (BMB) performed during investigation of B-symptoms or unexplained cytopaenias.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.